ALK6 (BMPR1B ), actif, GST étiqueté humain, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées Sf9, >=70% (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5283-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

ALK6 (also known as BMPR1B) is a member of the transmembrane serine/threonine kinase that is the member of the bone morphogenetic protein (BMP) receptor, ...


en savoir plus

Votre prix
£432.00 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

ALK6 (also known as BMPR1B) is a member of the transmembrane serine/threonine kinase that is the member of the bone morphogenetic protein (BMP) receptor, which is closely related to the activin receptors, ACVR1 and ACVR2. ALK6 is mainly involved in the endochondral bone formation and embryogenesis. ALK6 expressed in normal and cancerous prostate tissues and used in the endocrine therapy that given to the prostate cancer patients. ALK6 receptor trafficking also play a significant role in FOP pathogenesis and used in human T-cell differentiation.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM glutathione, 0.1 mM EDTA, 0.25 mM DTT, 0.1 mM PMSF, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

assay≥70% (SDS-PAGE)
formbuffered aqueous glycerol solution
Gene Informationhuman ... BMPR1B(658)
mol wt~68 kDa
NCBI accession no.NM_001203
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity16.2-26.5 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: